Form 8-K - Current report:
SEC Accession No. 0001079973-24-001194
Filing Date
2024-08-09
Accepted
2024-08-09 17:05:44
Documents
17
Period of Report
2024-08-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 42891
2 PRESS RELEASE ex99x1.htm EX-99.1 7462
3 STOCKHOLDER LETTER ex99x2.htm EX-99.2 13192
4 GRAPHIC image_002.jpg GRAPHIC 10100
  Complete submission text file 0001079973-24-001194.txt   305819

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE scpx-20240806.xsd EX-101.SCH 3549
6 XBRL DEFINITION FILE scpx-20240806_def.xml EX-101.DEF 26579
7 XBRL LABEL FILE scpx-20240806_lab.xml EX-101.LAB 36527
8 XBRL PRESENTATION FILE scpx-20240806_pre.xml EX-101.PRE 25203
19 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5512
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

EIN.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 241193883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)